Veloxis Pharmaceuticals A/S operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Veloxis Pharmaceuticals A/S with three other
miscellaneous service companies in Europe:
Brain Biotechnology Research and Information Network AG
sales of 26.42 million Euro [US$32.45 million]
of which 51%
of the United Kingdom
(£20.79 million [US$29.12 million]
of which 69%
was Research and development), and
based in France
(29.60 million Euro [US$36.36 million]
Sales increased substantially in 2017:
During the year ended December of 2017, sales at
Veloxis Pharmaceuticals A/S were 196.99 million Danish Kroner (US$32.50 million).
increase of 217.7%
versus 2016, when the company's sales were 62.00 million Danish Kroner.